2,4-DISULFONYL-α-PHENYL-TERT-BUTYLNITRON, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FORM OF FREE ACID OR SALT FORM THEREOF, PHARMACEUTICAL COMPOSITIONS AND METHODS OF MEDICAL TREATMENT Russian patent published in 2000 - IPC

Abstract RU 2159231 C2

FIELD: medicine. SUBSTANCE: described is new 2,4-disulfo-alpha-phenyl- tert-butylnitron compound of formula I and pharmaceutically acceptable salts thereof. These compounds are useful as pharmaceutical agents for parenteral, e.g. intraveous injection to patients suffering from acute oxidation of central nervous system which occurs during shock, or from gradual oxidation of central nervous system. These agents are also useful for weakening intensity of side effects in treating diseases which cause oxidative disorder. Also described are pharmaceutical composition and methods of medical treatment using compounds of general formula I. EFFECT: improved properties of the pharmaceutical composition and more efficient medical treatment methods. 22 cl, 14 ex, 6 tbl

Similar patents RU2159231C2

Title Year Author Number
PHARMACEUTICAL COMPOSITIONS, COMPOUNDS, METHODS OF SYNTHESIS OF COMPOUNDS 1995
  • Chu Chung K.
  • Cheng Jung-Chi
RU2168995C2
MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C 2008
  • Sjuj, Dzun
  • Ehsmon, Charl'Z
RU2539729C2
ADRENOCORTICOTROPIC HORMONE ANALOGUES AND RELATED METHODS 2005
  • Brennan Majlz B.
  • Dores Robert M.
  • Khaskell-Luvano Kehrri
  • Khokhgeshvender Ute Kh.
  • Kosta Dzhessika I.
RU2407751C2
TAXANES, PHARMACEUTICAL COMPOSITIONS, INHIBITION METHOD 2001
  • Kholton Robert A.
RU2265019C2
TAXANE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR INHIBITION OF TUMOR GROWTH 2001
  • Kholton Robert A.
RU2264400C2
PHARMACEUTICAL COMPOSITION CONTAINING VERBENOL DERIVATIVE FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASE 2013
  • Kim Von Ki
  • Chkhve Ensok
  • Son Sumi
RU2611349C2
PLATELET-SPECIFIC CHIMERIC IMMUNOGLOBULIN AND METHODS OF ITS USING 1994
  • Barri S.Koller
  • Dehvid N.Najt
RU2158135C2
CCI-779 FOR AMPHICYTE LYMPHOMA TREATMENT 2004
  • Uitzig Tomas Eh.
  • Kaufmann Skott Kh.
RU2358731C2
USE OF ACYLFULVEN ANALOGS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1994
  • Majkl Dzh.Kelner
  • Trevor S.Makmorris
  • Rajmond Titl
RU2145849C1
L-NUCLEOSIDES ELICITING ANTI-HBV OR ANTI-EBV ACTIVITY, METHOD OF INHIBITION OF HBV OR EBV INFECTION 1995
  • Chu Chang K.
  • Cheng Jung-Chi
  • Raj Balakrishana S.
  • Jao Gang-Kving
RU2171809C2

RU 2 159 231 C2

Authors

Dzhon M. Karni

Dates

2000-11-20Published

1994-12-22Filed